Start: June 1, 2018
End: July 16, 2021
What Is This Study About?
This clinical trial will test an experimental software program designed to improve cognitive function in older adults with age-related cognitive decline.
Do I Qualify To Participate in This Study?
- Fluent English speaker
- Adequate sensorimotor capacity to perform the program, including ability to read from a computer screen at a normal viewing distance, hear and understand normal speech, and control a computer mouse
Must NOT have:
- Evidence of dementia
- Any medical illnesses, injuries, or conditions predisposing participant to imminent functional and/or cognitive decline
- Requires caregiver assistance in dressing or personal hygiene
- Severe visual or hearing deficits
- Participation in computer-delivered cognitive training within past 2 years
- Claustrophobia or any other contraindication to MRI scanning; inability to complete a 1-hour MRI
- Implanted devices above the waist (e.g., cardiac pacemaker or auto-defibrillator, neural pacemaker, aneurysm clip, cochlear implant, metallic bodies in the eye or central nervous system, any form of wires or metal devices that may concentrate radio frequency fields)
- Active suicidal ideation with specific plan and intent or suicide-related behaviors within past 2 months
If I Qualify, Who Do I Contact?
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Where Is This Study Located?
Lead: Posit Science Corporation
University of Iowa
The University of Texas at Dallas
National Institute on Aging (NIA)
Source: ClinicalTrials.gov ID: NCT03197454